| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 05/13/2009 | CN101428143A Attenuation bacteria carrier tuberculosis vaccine carrying tuberculosis, preparation method and application thereof |
| 05/13/2009 | CN101428125A Medicament composition with antiviral efficacy |
| 05/13/2009 | CN101428114A Medicament for treating chronic hepatitis B, cirrhosis and liver ascites |
| 05/13/2009 | CN101428104A Chinese medicinal composition for treating obstinate syphilis |
| 05/13/2009 | CN101428087A Method of preparing plaster for quickly curing ulcer between toes |
| 05/13/2009 | CN101428070A Antiviral wind-removing traditional Chinese medicine and preparation method thereof |
| 05/13/2009 | CN101428057A Antimicrobial powder for reinforcing immune, strengthening the body resistance and removing toxicity for livestock and poultry |
| 05/13/2009 | CN101428049A Upper respiratory tract infection resistant medicament composition, preparation and uses thereof |
| 05/13/2009 | CN101428047A Process for producing pericarpium granati total phenols and uses thereof |
| 05/13/2009 | CN101428044A Novel broad spectrum antiphlogistic pain-easing medicament for treating multiple oral diseases |
| 05/13/2009 | CN101428026A New use of 8-substituted dihydrobenzene-[C]phenanthridine alkaloids in producing anti-drug-fast bacteria medicament |
| 05/13/2009 | CN101428020A Freeze-dried powder preparation of kuh-seng native, preparation and detection method thereof |
| 05/13/2009 | CN101428016A Uses of di-indole methyl hydride and its derivant in treating rheumatoid arthritis |
| 05/13/2009 | CN101428006A Microparticle compositions and methods for the manufacture thereof |
| 05/13/2009 | CN100487453C Quality control method of oral preparation for heat clearing and exterior resolution |
| 05/13/2009 | CN100487000C Carboxymethyl chitosan quaternary ammonium salt and its preparation method |
| 05/13/2009 | CN100486987C Antivira and antitumor deoxyoligonucleotide containing CpG single strand |
| 05/13/2009 | CN100486642C 疫苗 Vaccine |
| 05/13/2009 | CN100486631C Chinese traditional medicinal formula for treating AIDS |
| 05/13/2009 | CN100486612C Soft capsule containing Bupleurum and Radix scutellariae, preparation method and use thereof |
| 05/13/2009 | CN100486599C Application of spanishneedles herb flavonid in preparing medicine for preventing and treating viral hepatitis |
| 05/13/2009 | CN100486598C Bupleurum root asarum herb dripping pill and its preparing method |
| 05/13/2009 | CN100486597C A pharmaceutical composition made from Chinese traditional medicine for treating snuffle, headache and preparation method thereof |
| 05/13/2009 | CN100486588C Single-chain deoxidized oligonucleotide containing CPG of resisting infuenza virus |
| 05/13/2009 | CN100486587C Clarithromycin liposome microsphere injection and its preparation method |
| 05/13/2009 | CN100486576C Substituted pyridinones as modulators of P38MAP kinase |
| 05/13/2009 | CN100486573C Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and use |
| 05/12/2009 | US7531661 Such as N-methyl(1-{2-[(1R,5S)-3-(2-methyl-1H-benzimidazol-1-yl)-8-azabicyclo[3.2.1]oct-8-yl]ethyl}-2,3-dihydro-1H-inden-1-yl)methanamine; chemokine receptor antagonists; prevention or treatment of a human T-cell leukemia/lymphoma virus infection |
| 05/12/2009 | US7531636 A proinflammatory cytokine; monoclonal antibodies, or mixture of polyclonal antibodies; blocks signal transduction; hematopoietic cell proliferation |
| 05/12/2009 | US7531633 Immunotherapy against infection; harvesting antibodies directed against Staphylococcus from blood of immunized subject for use as immunotherapeutic agents |
| 05/12/2009 | US7531548 to inhibit the replication of mutant strains, in particular strains which are resistant to NNRTI drugs (Non Nucleoside Reverse Transcriptase Inhibitor drugs); to treat HIV infections |
| 05/12/2009 | US7531540 phosphodiesterase type 4 inhibitors; to treat respiratory disorders, skin disorders like psoriasis and atopic eczema; low toxicity, high bioavailability, no significant side effects; 2-{4-[(4aS,8aR)-4-(3,4-dimethoxyphenyl)-1-oxo-4a,5,8,8a-tetrahydro-1H-phthalazin-2-yl]-piperidin-1-yl}-acetamide |
| 05/12/2009 | US7531536 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 05/12/2009 | US7531531 Method of treating diseases associated with altered kinase activity with bicyclo-pyrazoles |
| 05/12/2009 | US7531526 Boronic ester and acid compounds, synthesis and uses |
| 05/12/2009 | US7531516 Antiinflammatory agents; multiple sclerosis; inflamamtory bowel disorders; antitumor agents; sepsis |
| 05/12/2009 | US7531509 Cationic peptide that inhibits the growth of both grampositive and/or gramnegative bacteria; isolated from the hemocytes of the sea squirt; can be used to treat antibiotic resistant tuberculosis, pneumonia, and urinary pathologies |
| 05/12/2009 | US7531504 Peptide antagonists of zonulin that bind to the zonula occludens receptor, yet do not physiologically modulate the opening of mammalian tight junctions; tablets, capsules |
| 05/12/2009 | US7531183 Biologically active hemagglutinin from type A Clostridium botulinum and methods of use |
| 05/12/2009 | US7531182 Vaccine against foot-and-mouth disease |
| 05/12/2009 | US7531175 Methods for modulation of immune responses using humanized immunoglobulins reactive with B7-1 molecules |
| 05/12/2009 | US7531171 Antibodies to non-functional P2X7 receptor |
| 05/12/2009 | CA2437785C Hiv inhibiting pyrazinone derivatives |
| 05/12/2009 | CA2377301C Controlled release and taste masking oral pharmaceutical compositions |
| 05/12/2009 | CA2356080C Improved formulation for transportation of corticosteroid through pores of a barrier |
| 05/12/2009 | CA2324921C Trisubstituted 1,3,5-triazine derivatives for treatment of hiv infections |
| 05/12/2009 | CA2272338C Immunization of infants |
| 05/12/2009 | CA2228266C Use of l-carnitine and derivatives for reducing ceramide levels and potentiating antiretroviral drugs |
| 05/07/2009 | WO2009058857A1 Mitigation of animal and plant diseases using bioavailable minerals |
| 05/07/2009 | WO2009058856A1 Macrocyclic inhibitors of hepatitis c virus ns3 serine protease |
| 05/07/2009 | WO2009058387A2 Oligomer-nitroimidazole anti-infective conjugates |
| 05/07/2009 | WO2009057768A1 Anti-fungal agent and anti-bacterial agent |
| 05/07/2009 | WO2009057763A1 Novel adjuvant |
| 05/07/2009 | WO2009057568A1 Polypeptide compound |
| 05/07/2009 | WO2009056818A1 Novel antiretroviral combination |
| 05/07/2009 | WO2009056535A2 Methods and kits for inducing a ctl response using a prime boost regimen |
| 05/07/2009 | WO2009056322A2 Foam stabilizer for a sterilization composition |
| 05/07/2009 | WO2009056076A1 Engineered pertactin variants for vaccine use |
| 05/07/2009 | WO2009055936A1 Humanized anti-venezuelan equine encephalitis virus recombinant antibodies |
| 05/07/2009 | WO2009055857A1 Calcium-rich alkaline powder produced from processed molluse shells |
| 05/07/2009 | WO2009035420A8 Monoclonal antibodies specific to hemagglutinin and neuraminidase from influenza virus h5-subtype or n1-subtype and uses thereof |
| 05/07/2009 | WO2009033745A3 Use of a peptide as a therapeutic agent |
| 05/07/2009 | WO2008148563A3 Viral latency model |
| 05/07/2009 | WO2008106979A3 Pharmaceutical compositions comprising flavonoids and xylitol |
| 05/07/2009 | WO2008095040A3 2-5a derivatives and their use as anti-cancer, anti-viral and anti-parasitic agents |
| 05/07/2009 | WO2007055760A3 Protein composition for promoting wound healing and skin regeneration |
| 05/07/2009 | WO2007008684A3 Ligands of melanocortin receptors |
| 05/07/2009 | US20090118486 Uspa1 and uspa2 antigens of moraxella catarrhalis |
| 05/07/2009 | US20090118352 Broad spectrum microbicidal and spermicidal compositions and methods |
| 05/07/2009 | US20090118339 Lysine related derivatives as hiv aspartyl protease inhibitors |
| 05/07/2009 | US20090118332 Therapeutic Agents - 551 |
| 05/07/2009 | US20090118329 Novel Substituted 2-Amino-4-Phenyldihydroquinolines, Processes for their Preparation, Pharmaceutical Compositions and Methods for Their Use |
| 05/07/2009 | US20090118312 flavivirus antivirals based on1,6-diazacyclotetradecane with fused pyrrolidine or cyclopentane ring at positions 3,4 and methylene bridge at positions 7,8; macrocyclic ring substituted with quinazolin-4-yloxy substituent on the fused pyrrolidine or cyclopentane ring |
| 05/07/2009 | US20090118308 2,2-Bis-(hydroxymethyl)cyclopropylidenemethyl-Purines and -Pyrimidines As Antiviral Agents |
| 05/07/2009 | US20090118298 Octahydropentalene compounds as chemokine receptor antagonists |
| 05/07/2009 | US20090118233 Heterocyclic compounds having inhibitory activity against HIV integrase |
| 05/07/2009 | US20090118230 Fucose containing proteoglycan or acidic glycan and their pharmaceutical use |
| 05/07/2009 | US20090118227 Carotenoid-containing compositions and methods |
| 05/07/2009 | US20090118223 Novel 2'-c-methyl and 4'c-methyl nucleoside derivatives |
| 05/07/2009 | US20090118220 Substituted adenines and the uses thereof |
| 05/07/2009 | US20090118214 Compositions for conferring tolerance to viral disease in social insects, and the use thereof |
| 05/07/2009 | US20090118168 Topical adminstration of acyclovir |
| 05/07/2009 | US20090117586 Fungal cell wall synthesis gene |
| 05/07/2009 | US20090117201 Multi-purpose acid compositions |
| 05/07/2009 | US20090117193 Compositions Comprising an Active Agent |
| 05/07/2009 | US20090117173 Antimicrobial glaze and poreclain enamel via double layer glaze with high zinc content |
| 05/07/2009 | US20090117168 Device and method for attaracting diseased cells and foreign substances |
| 05/07/2009 | US20090117150 Functional Mutations In Respiratory Syncytial Virus |
| 05/07/2009 | US20090117148 Capsular Polysaccharides Solubilisation and Combination Vaccines |
| 05/07/2009 | US20090117135 Vaccine comprising an antigen conjugated to low valency anti-cd40 or anti-cd28 antibodies |
| 05/07/2009 | US20090117133 POLYMERIC IMMUNOGLOBULIN FUSION PROTEINS THAT TARGET LOW AFFINITY FCyRECEPTORS |
| 05/07/2009 | US20090117123 Immunopeptides of hpv e6 and e7 proteins |
| 05/07/2009 | US20090117115 Binary epitope antibodies and B cell superantigen immune stimulants |
| 05/07/2009 | US20090117113 Immunogenic And Therapeutic Compositions For Streptococcus Pyogenes |
| 05/07/2009 | US20090117110 Method for the In Vitro Assessment of the Progression Status of an Infection by an HIV Virus in an Individual |
| 05/07/2009 | US20090117109 Methods For Reducing Biofilm Formation In Infectious Bacteria |
| 05/07/2009 | US20090117086 Preparation of replicating macrophages and use in diagnosis and therapy |
| 05/07/2009 | US20090117082 Reovirus for the Treatment of Cellular Proliferative Disorders |
| 05/07/2009 | US20090117057 Grape Polyphenolics for Platelet and Bacterial Control |
| 05/07/2009 | US20090117037 Methods Of Treatment Using CTLA-4 Antibodies |